This company has been marked as potentially delisted and may not be actively trading. NASDAQ:DALS DA32 Life Science Tech Acquisition (DALS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About DA32 Life Science Tech Acquisition Stock (NASDAQ:DALS) 30 days 90 days 365 days Advanced Chart Get DALS alerts:Sign Up Key Stats Today's Range$10.30▼$10.3250-Day Range$10.25▼$10.3252-Week Range$9.68▼$11.22Volume2,248 shsAverage Volume88,802 shsMarket Capitalization$264.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewDA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.Read More… Receive DALS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DA32 Life Science Tech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address DALS Stock News HeadlinesPalmer Luckey and other defense tech leaders see Trump's victory as a win for the industryNovember 11, 2024 | msn.comRLST:CA RBC Funds - RBC Life Science and Technology FundOctober 22, 2024 | seekingalpha.comTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be laughable if it wasn’t putting so many Americans’ financial futures at severe risk… That’s why, with the 100-day mark of Trump’s second term just days away, it’s time to shine a light on what’s really going on, because if you move your money out of the wrong places and into the right ones before it’s too late… …you could be one of the few who profits from this imminent trillion-dollar reset.May 8, 2025 | Porter & Company (Ad)NASA Selects Two Teams to Advance Life Sciences Research in SpaceOctober 17, 2024 | msn.comHere are the top tech startups disrupting the defense industry — and what they're sellingSeptember 15, 2024 | msn.comT. Rowe Price Science & TechSeptember 12, 2024 | morningstar.comGlobal Technology Acquisition Corp I (GTAC)August 2, 2024 | investing.comDA32 Life Science Tech Acquisition Corp.July 19, 2024 | thestreet.comSee More Headlines DALS Stock Analysis - Frequently Asked Questions When did DA32 Life Science Tech Acquisition IPO? DA32 Life Science Tech Acquisition (DALS) raised $200 million in an initial public offering (IPO) on Wednesday, July 28th 2021. The company issued 20,000,000 shares at a price of $10.00 per share. What other stocks do shareholders of DA32 Life Science Tech Acquisition own? Based on aggregate information from My MarketBeat watchlists, some other companies that DA32 Life Science Tech Acquisition investors own include Bridge Investment Group (BRDG), Blend Labs (BLND), Blue Foundry Bancorp (BLFY), Couchbase (BASE), ARYA Sciences Acquisition Corp V (ARYE), Argo Blockchain (ARBK) and a.k.a. Brands (AKA). Company Calendar Today5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:DALS CIK1863294 Webda32lifescience.tech Phone212551600FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$600,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-37.55% Return on Assets0.85% Debt Debt-to-Equity RatioN/A Current Ratio0.36 Quick Ratio0.36 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.02 per share Price / Cash Flow441.92 Book Value($0.18) per share Price / Book-57.33Miscellaneous Outstanding SharesN/AFree FloatN/AMarket Cap$264.71 million OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:DALS) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersIt may already be too late… A global energy shift is underway—and lithium is at the center of it. From electric vehicles to grid storage a...Huge Alerts | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[FREE GIFT] New AI for retail tradersTradeAlgo has found a “backdoor way” for retail traders to profit from the AI arms race by developing its grou...TradeAlgo | SponsoredBitcoin Just Broke $100K – Are You Positioned?This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DA32 Life Science Tech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DA32 Life Science Tech Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
